In a previous study, a rapamycin-sensitive growth advantage in BNIP3-knockdown tumor xenografts was shown, suggesting that BNIP3 inhibits cell growth by suppressing the mTOR pathway [14]. This evidence concerns the gene BNIP3 and neoplasm.